Triglyceride to High-Density Lipoprotein Cholesterol Ratio is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study

References

• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290(3):374–380. doi:10.1001/jama.290.3.374
   PubMed Web of Science ®Google Scholar
• Hui DS, Azhar EI, Kim YJ, et al. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18(8):e217–227. doi:10.1016/S1473-3099(18)30127-0
   PubMed Web of Science ®Google Scholar
• Chen R, Liang W, Jiang M, et al. Risk factors of fatal outcome in hospitalized subjects with Coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158(1):97–105. doi:10.1016/j.chest.2020.04.010
   PubMed Web of Science ®Google Scholar
• Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14(4):535–545. doi:10.1016/j.dsx.2020.04.044
   PubMed Web of Science ®Google Scholar
• Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395–403. doi:10.1016/j.dsx.2020.04.018
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091
   PubMed Web of Science ®Google Scholar
• Marotta T, Russo BF, Ferrara LA. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. Obesity (Silver Spring). 2010;18(8):1608–1613. doi:10.1038/oby.2009.446
   PubMedGoogle Scholar
• Hajian-Tilaki K, Heidari B, Bakhtiari A. Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: evidence from a population-based cross-sectional study. Caspian J Intern Med. 2020;11(1):53–61. doi:10.22088/cjim.11.1.53
   PubMedGoogle Scholar
• Sanchez-Inigo L, Navarro-Gonzalez D, Pastrana-Delgado J, et al. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–1265. doi:10.1097/HJH.0000000000000941
   PubMedGoogle Scholar
• Farrell SW, Finley CE, Barlow CE, et al. Moderate to high levels of cardiorespiratory fitness attenuate the effects of triglyceride to high-density lipoprotein cholesterol ratio on coronary heart disease mortality in men. Mayo Clin Proc. 2017;92(12):1763–1771. doi:10.1016/j.mayocp.2017.08.015
   PubMedGoogle Scholar
• Yunke Z, Guoping L, Zhenyue C. Triglyceride-to-HDL cholesterol ratio. Predictive value for CHD severity and new-onset heart failure. Herz. 2014;39(1):105–110. doi:10.1007/s00059-013-3788-0
   PubMedGoogle Scholar
• Wan GX, Xia WB, Ji LH, et al. Triglyceride to high density lipoprotein cholesterol ratio may serve as a useful predictor of major adverse coronary event in female revascularized ST-elevation myocardial infarction. Clin Chim Acta. 2018;485:166–172. doi:10.1016/j.cca.2018.06.049
   PubMedGoogle Scholar
• New coronavirus pneumonia prevention and control program (6th ed.) (in Chinese); 2020. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/fil463es/b218cfeb1bc54639af227f922bf6b817.pdf.
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731. doi:10.1002/ejhf.1494
   PubMed Web of Science ®Google Scholar
• Salazar MR, Carbajal HA, Espeche WG, et al. Insulin resistance: the linchpin between prediabetes and cardiovascular disease. Diab Vasc Dis Res. 2016;13(2):157–163. doi:10.1177/1479164115610057
   PubMed Web of Science ®Google Scholar
• Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32(8):1754–1759. doi:10.1161/ATVBAHA.111.241885
   PubMed Web of Science ®Google Scholar
• Huggett RJ, Scott EM, Gilbey SG, et al. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circualtion. 2003;108(25):3097–3101. doi:10.1161/01.CIR.0000103123.66264.FE
   PubMed Web of Science ®Google Scholar
• Lee J, Lee S, Zhang H, et al. Interaction of IL-6 and TNF-alpha contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS One. 2017;12(11):e187189.
   PubMed Web of Science ®Google Scholar
• Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–880. doi:10.1038/nature05487
   PubMed Web of Science ®Google Scholar
• Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi:10.1038/nrendo.2014.29
   PubMed Web of Science ®Google Scholar
• Shrader CD, Bailey KM, Konat GW, et al. Insulin enhances proliferation and viability of human umbilical vein endothelial cells. Arch Dermatol Res. 2009;301(2):159–166. doi:10.1007/s00403-008-0921-7
   PubMedGoogle Scholar
• Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 2010;21(5):409–415. doi:10.1097/MOL.0b013e32833ded83
   PubMedGoogle Scholar
• Zhou M, Learned RM, Rossi SJ, et al. Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis. J Lipid Res. 2019;60(3):550–565. doi:10.1194/jlr.M089961
   PubMedGoogle Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Hulot JS. COVID-19 in patients with cardiovascular diseases. Arch Cardiocasc Dis. 2020;113(4):225–226. doi:10.1016/j.acvd.2020.03.009
   PubMedGoogle Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi:10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Chen Z, Hu H, Chen M, et al. Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study. Lipids Health Dis. 2020;19(1):33. doi:10.1186/s12944-020-01213-x
   PubMed Web of Science ®Google Scholar
• Rollins KE, Varadhan KK, Dhatariya K, Lobo DN. Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. Clin Nutr. 2016;35(2):308–316. doi:10.1016/j.clnu.2015.03.007
   PubMedGoogle Scholar
• Zhang Y, Li H, Zhang J, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycemia with coronavirus disease 2019: a single-centre, retrospective, observational study in Wuhan. Diabetes Obes Metab. 2020;22(8):1443–1454. doi:10.1111/dom.14086
   PubMed Web of Science ®Google Scholar
• Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27(1):125–136. doi:10.1016/j.stem.2020.06.015
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Wang C, Fei D, Li X, et al. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensive Care Med. 2020;46(7):1475–1476. doi:10.1007/s00134-020-06065-8
   PubMed Web of Science ®Google Scholar
• Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;e33213321. doi:10.1002/dmrr.3321
   PubMed Web of Science ®Google Scholar
• Li M, Dong Y, Wang H, et al. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr Metab Cardiovasc Dis. 2020;30(7):1061–1067. doi:10.1016/j.numecd.2020.04.013
   PubMed Web of Science ®Google Scholar